ArticleJournal of ovarian research2010

CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion.

Erica L Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.